Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-angiogenic Approach

NCT00250718 is registered in ClinicalTrials.gov with New Mexico Cancer Research Alliance as lead sponsor.

NCT NCT00250718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00250718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-angiogenic Approach
Lead sponsor
New Mexico Cancer Research Alliance
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2004
Completion date
May 31, 2014
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, non-hodgkin's lymphoma